Go Ad-Free
My Alerts
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
MARKETS

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

| BSE 1194.00 43.45 (3.78%) | |

BSE Live

Jan 30, 16:01
1194.00 43.45 (3.78%)
Volume
AVERAGE VOLUME
5-Day
10,601
10-Day
10,797
30-Day
23,869
809,889

  • Prev. Close

    1150.55

  • Open Price

    1190.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 30, 15:59
1207.70 57.10 (4.96%)
Volume
AVERAGE VOLUME
5-Day
596,550
10-Day
654,249
30-Day
800,425
8,127,226

  • Prev. Close

    1150.60

  • Open Price

    1190.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1207.70 (2033)

Financials

Cash Flow of Aurobindo Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 3,743.04 3,091.35 3,241.18 3,060.84 2,744.30  
Net CashFlow From Operating Activities 4,381.28 1,650.97 1,954.52 3,278.58 1,419.76  
Net Cash Used In Investing Activities -1,567.64 -2,902.59 -1,926.59 -1,787.04 -1,445.21  
Net Cash Used From Financing Activities -1,947.18 1,919.06 864.15 -1,915.26 365.44  
Foreign Exchange Gains / Losses 4.78 -1.80 -0.17 -0.14 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 871.24 665.64 891.91 -423.86 339.99  
Cash And Cash Equivalents Begin of Year 1,875.58 1,209.94 318.03 743.49 403.81  
Cash And Cash Equivalents End Of Year 2,746.82 1,875.58 1,209.94 319.63 743.80  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347